Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response
- PMID: 15805178
- PMCID: PMC2718466
- DOI: 10.1164/rccm.200412-1747OC
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response
Abstract
Rationale: Moraxella catarrhalis is frequently present in the sputum of adults with chronic obstructive pulmonary disease (COPD). Little is known about the role of M. catarrhalis in this common disease.
Objective: To elucidate the burden of disease, the dynamics of carriage, and immune responses to M. catarrhalis in COPD.
Methods: Prospective cohort study of 104 adults with COPD in an outpatient clinic at the Buffalo Veterans Affairs Medical Center.
Measurements: Clinical information, sputum cultures, molecular typing of isolates, and immunoassays to measure antibodies to M. catarrhalis.
Main results: Over 81 months, 104 patients made 3,009 clinic visits, 560 during exacerbations. Molecular typing identified 120 episodes of acquisition and clearance of M. catarrhalis in 50 patients; 57 (47.5%) of the acquisitions were associated with clinical exacerbations. No instances of simultaneous acquisition of a new strain of another pathogen were observed. The duration of carriage of M. catarrhalis was shorter with exacerbations compared with asymptomatic colonization (median, 31.0 vs. 40.4 days; p = 0.01). Reacquisition of the same strain was rare. The intensity of the serum IgG response was greater after exacerbations than asymptomatic colonization (p = 0.009). Asymptomatic colonization was associated with a greater frequency of a sputum IgA response than exacerbation (p = 0.009).
Conclusions: M. catarrhalis likely causes approximately 10% of exacerbations of COPD, accounting for approximately 2 to 4 million episodes annually. The organism is cleared efficiently after a short duration of carriage. Patients develop strain-specific protection after clearance of M. catarrhalis from the respiratory tract.
Figures
Comment in
-
Bacteria and airway inflammation in chronic obstructive pulmonary disease: more evidence.Am J Respir Crit Care Med. 2005 Jul 15;172(2):147-8. doi: 10.1164/rccm.2504004. Am J Respir Crit Care Med. 2005. PMID: 16002571 Review. No abstract available.
References
-
- Wilson R. The role of infection in COPD. Chest 1998;113:242S–248S. - PubMed
-
- Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 1975;292:563–571. - PubMed
-
- Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288–295. - PubMed
-
- Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015–1022. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
